AI assistant
MAYNE PHARMA GROUP LIMITED — Share Issue/Capital Change 2022
Oct 27, 2022
65396_rns_2022-10-27_44082256-2b72-4d07-8643-63e905e49daa.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Notification of Consolidation/Split
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
MAYNE PHARMA GROUP LIMITED
Applicable security for the reorganisation
| MYX | ORDINARY FULLY PAID |
|---|---|
| MYXAN | PERFORMANCE RIGHTS |
| MYXAT | OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES |
Announcement Type
New Announcement
Date of this announcement
28/10/2022
Reorganisation type
Security consolidation
Trading in the post consolidation or split +securities commences on a deferred settlement basis 18/1/2023
Record Date
19/1/2023
Issue Date
24/1/2023
Refer to below for full details of the announcement
Notification of Consolidation/Split
1 / 5
Notification of Consolidation/Split
==> picture [21 x 22] intentionally omitted <==
Announcement Details
Part 1 - Entity and announcement details
1.1 Name of +Entity
MAYNE PHARMA GROUP LIMITED
1.2 Registered Number Type Registration Number ABN 76115832963 1.3 ASX issuer code MYX 1.4 The announcement is New announcement
1.5 Date of this announcement
28/10/2022
1.6 Securities affected by the consolidation or split
ASX +Security Code ASX +Security Description MYX ORDINARY FULLY PAID MYXAN PERFORMANCE RIGHTS MYXAT OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Part 2 - Approvals
2.1 Are any of the below approvals required for the consolidation or split before business day 0 of the timetable? Security holder approval Court approval Lodgement of court order with +ASIC ACCC approval FIRB approval Another approval/condition external to the entity required to be given/met before business day 0 of the timetable for the consolidation or split.
Notification of Consolidation/Split
2 / 5
Notification of Consolidation/Split
==> picture [21 x 22] intentionally omitted <==
==> picture [8 x 6] intentionally omitted <==
Yes
2.2 Approvals
Approval/Condition Date for determination +Security holder approval 30/11/2022
Is the date estimated or Approval actual? received/condition met? Actual No
Comments
Part 3 - Consolidation or split timetable and details
3.1 +Record date
19/1/2023
3.2 Date of +security holder meeting
30/11/2022
3.2a Effective date of consolidation or split
16/1/2023
3.3 Last day for trading in the pre consolidation or split +securities
17/1/2023
3.4 Trading in the post consolidation or split +securities commences on a deferred settlement basis.
18/1/2023
3.5 Record date
19/1/2023
3.6 First day for entity to update its register and to send holding statements to +security holders reflecting the change in the number of +securities they hold.
20/1/2023
3.7 Last day for entity to update its register and send holding statements to +security holders reflecting the change in the number of +securities they hold and to notify ASX that this has occurred. (+Issue Date) 24/1/2023
3.8 Trading starts on a normal T+2 basis
25/1/2023
3.9 First settlement of trades conducted on a +deferred settlement basis and on a normal T+2 basis
30/1/2023
Notification of Consolidation/Split
3 / 5
Notification of Consolidation/Split
==> picture [21 x 22] intentionally omitted <==
Part 4 - Event type and details
4.1 The event is
==> picture [8 x 8] intentionally omitted <==
+Security consolidation
4.1a Consolidation ratio: the +securities will be consolidated on the basis that every
20
(pre-consolidation) +securities will be consolidated into
1
(post-consolidation) +security (/ies).
4.2 Scrip fraction rounding
Fractions rounded down to the nearest whole number or fractions disregarded
Part 5 - +Securities on issue before and after consolidation or split
5.1 +Securities on issue before and after the consolidation or split
| ASX +Security Code | ASX +Security Description | ||
|---|---|---|---|
| MYX | ORDINARY FULLY PAID | ||
| Quoted/unquoted | Number on issue pre | Number on issue post | Estimate/Actual |
| Quoted | consolidation or split | consolidation or split | Estimated |
| 1,739,815,508 | 86,990,775 | ||
| ASX +Security Code | ASX +Security Description | ||
| MYXAN | PERFORMANCE RIGHTS | ||
| Quoted/unquoted | Number on issue pre | Number on issue post | Estimate/Actual |
| Unquoted | consolidation or split | consolidation or split | Estimated |
| 59,051,842 | 2,952,592 | ||
| ASX +Security Code | ASX +Security Description | ||
| MYXAT | OPTION EXPIRING VARIOUS | DATES EX VARIOUS PRICES | |
| Quoted/unquoted | Number on issue pre | Number on issue post | Estimate/Actual |
| Unquoted | consolidation or split | consolidation or split | Estimated |
| 16,706,827 | 835,341 |
5.2 Exercise price of options
| ASX +Security Code | ASX +Security Description | |
|---|---|---|
| MYXAN | PERFORMANCE RIGHTS | |
| Quoted/unquoted | Exercise price pre consolidation or | Exercise price post consolidation or |
Notification of Consolidation/Split
4 / 5
Notification of Consolidation/Split
==> picture [21 x 22] intentionally omitted <==
| Unquoted | split | split |
|---|---|---|
| 0.00000000 | 0.00000000 | |
| ASX +Security Code | ASX +Security Description | |
| MYXAT | OPTION EXPIRING VARIOUS DATES | EX VARIOUS PRICES |
| Quoted/unquoted | Exercise price pre consolidation or | Exercise price post consolidation or |
| Unquoted | split | split |
| 0.00000000 | 0.00000000 |
Part 6 - Further information
6.1 Further information relating to the consolidation or split
MYXAN option exercise prices will be adjusted as follows: Options expiring 30 Sep 2025 with exercise price of 0.2929 will be adjusted to 5.858 Options expiring 30 Sep 2025 with exercise price of 0.3174 will be adjusted to 6.348 Options expiring 31 March 2026 with exercise price of 0.2813 will be adjusted to 5.626
6.2 Additional information for inclusion in the Announcement Summary
Notification of Consolidation/Split
5 / 5